El consentimiento informado en pacientes con trastornos psiquiátricos

[ES] Se resalta el importante cambio cultural que supone el consentimiento informado en pacientes con trastornos psiquiátricos, considerándolo como un proceso de comunicación e información entre el profesional sanitario y la persona atendida, para promover una decisión explicita y autónoma del paciente sobre una determinada actuación de la que ha ponderado riesgos, beneficios y alternativas.[EU] Artikulu honetan azpimarratzen da adierazitako baimena gaixotasun psikiatrikoak dituzten gaixoengan garrantzizko aldaketa kulturala izan dela, profesional sanitarioa eta gaixoaren arteko komunikazio eta informaziozko prozesu bat kontsideratuz, gaixoaren erabaki garbi eta autonomoa bultzatzeko jardun zehatz bati buruz, zeinean arrisky, onura eta aukerak neurtu dituen.[FR] Il est mis en valeur l'important changement culturel qu'implique le consentement informé des patients avec des troubles psychiatriques, en considérant ce consentement comme un procès de communication et d'information entre le professionnel sanitaire et la personne soignée, pour promouvoir une décision explicite et autonome du patient sur une action déterminée de laquelle il a examiné les risques, les bénefices et les alternatives.[EN] The important cultural change in relation to the informed consent of patients with psychiatric disorders is highlighted. This is considered as a communication and information process between sanitary professionals and the treated person, to promote an explicit and autonomous decision of the patient about a specific intervention about which he considers risks, advantages and alternatives

El consentimiento informado en pacientes con trastornos psiquiátricos

[ES] Se resalta el importante cambio cultural que supone el consentimiento informado en pacientes con trastornos psiquiátricos, considerándolo como un proceso de comunicación e información entre el profesional sanitario y la persona atendida, para promover una decisión explicita y autónoma del paciente sobre una determinada actuación de la que ha ponderado riesgos, beneficios y alternativas.[EU] Artikulu honetan azpimarratzen da adierazitako baimena gaixotasun psikiatrikoak dituzten gaixoengan garrantzizko aldaketa kulturala izan dela, profesional sanitarioa eta gaixoaren arteko komunikazio eta informaziozko prozesu bat kontsideratuz, gaixoaren erabaki garbi eta autonomoa bultzatzeko jardun zehatz bati buruz, zeinean arrisky, onura eta aukerak neurtu dituen.[FR] Il est mis en valeur l'important changement culturel qu'implique le consentement informé des patients avec des troubles psychiatriques, en considérant ce consentement comme un procès de communication et d'information entre le professionnel sanitaire et la personne soignée, pour promouvoir une décision explicite et autonome du patient sur une action déterminée de laquelle il a examiné les risques, les bénefices et les alternatives.[EN] The important cultural change in relation to the informed consent of patients with psychiatric disorders is highlighted. This is considered as a communication and information process between sanitary professionals and the treated person, to promote an explicit and autonomous decision of the patient about a specific intervention about which he considers risks, advantages and alternatives

Hereditary pancreatic cancer: related syndromes and clinical perspective

Abstract Pancreatic cancer is a very aggressive disease with a poor prognosis. The majority of them are attributed to sporadic causes, especially to many modifiable risk factors such as tobacco or alcohol abuse. The principal histologic subtype of pancreatic cancer is ductal adenocarcinoma. Pancreatic neuroendocrine tumors, which constitute a more indolent entity, represent second type of pancreatic cancer in terms of incidence. Individuals with a family history of pancreatic cancer carry an increased risk of developing the disease, which may be related to an underlying hereditary component. Unfortunately, in the majority of these families the suspected germline genetic cause responsible of the disease will not be identified, but approximately in a 20% of the cases a hereditary cancer predisposition syndrome with increased risk of pancreatic cancer development can be recognized. This review will be focused on the leading hereditary cancer syndromes related to pancreatic ductal adenocarcinoma and pancreatic neuroendocrine tumors. Additionally, we will try to explain clinical aspects related to the identification of germline mutations in pancreatic cancer patients and their potential implications in oncologic treatment decisions